Portfolio Companies News
July 17, 2017Strongbridge Biopharma plc Secures ...
~ Financing Comprised of $50 Million Credit Facility and $3 Million Equity Investment ~ ~ Simultaneously Retiring Existing Debt ~ ~ Funds Received at Close Provide Sufficient Cash Under Current Operating Plan to Extend Cash Runway to Positive Cash Flow~ DUBLIN, Ireland and TREVOSE, Pa., July 17... read more
July 12, 2017Bonesupport: Pipeline Project Targe...
Lund, Sweden, 12 July 2017– BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery, announced today that one of the components of its pipeline projects focused on developing a new... read more
July 11, 2017Orexo Interim Report Q2 2017 and bu...
Financial overview Q2 2017 Total net revenues SEK 159.1 million (188.2) Zubsolv® US net revenue SEK 124.1 million (112.8) EBIT SEK 9.8 million (12.1) EBITDA SEK 15.0 million (17.2) Earnings per share, before and after dilution, SEK 0.09/0.09 (0.14/0.14) Cash flow from operating... read more
July 11, 2017Nordic Nanovector ASA: Increase of ...
Oslo, Norway, 10 July 2017 Three of the board members of Nordic Nanovector ASA (the "Company") (OSE: NANO), Gisela Schwab, Joanna Horobin and Jean-Pierre Bizzari, have resolved to settle a total number of 13,259 RSUs that were issued pursuant to an authorisation granted to the board of directors ... read more
July 5, 2017Nordic Nanovector ASA: Mandatory no...
On 5 July 2017, Dr. Lisa Rojkjaer, MD, the CMO of Nordic Nanovector ASA, purchased 2,000 shares in the company at an average share price of NOK 68.50 per share. Following this transaction, Lisa Rojkjaer owns 4,186 shares in the Company and holds 375,000 options. This information is subject to dut... read more
July 14, 2017Q2 2017 General Market Overview
Since the start in 1996, HealthCap funds have invested in 108 portfolio companies.
41 of the portfolio companies have been taken public on nine different markets.
22 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.